Different factors have impact on severe pneumonia resolution and mortality after the initial treatment period

V. Dudzevicius, A. Vitkauskiene, R. Sakalauskas (Kaunas, Lithuania)

Source: Annual Congress 2003 - Clinical aspects of community-acquired pneumonia
Session: Clinical aspects of community-acquired pneumonia
Session type: Thematic Poster Session
Number: 978
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Dudzevicius, A. Vitkauskiene, R. Sakalauskas (Kaunas, Lithuania). Different factors have impact on severe pneumonia resolution and mortality after the initial treatment period. Eur Respir J 2003; 22: Suppl. 45, 978

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Factors influencing initial treatment effect and outcome of pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 478s
Year: 2002

Potential causes of increased long-term mortality after pneumonia
Source: Eur Respir J 2011; 37: 1306-1307
Year: 2011


Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2011; 39: 156-162
Year: 2012



Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2012; 39: 156-162
Year: 2012



The main risk factors of the community-acquired pneumonia delayed course
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005

Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004

The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008



Risk factors for bacterial infection in exacerbated COPD requiring admission
Source: Eur Respir J 2001; 18: Suppl. 33, 153s
Year: 2001

Clinical characteristics, outcomes and factors associated with mortality in nocardia pneumonia: 10 year experience from a developing country
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019


Inflammatory responses predict long-term mortality risk in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 1439-1446
Year: 2011



The problem of early mortality in pneumococcal pneumonia: a study of risk factors
Source: Eur Respir J 2015; 46: 561-564
Year: 2015


Relationship between selected initial treatment of healthcare associated pneumonia with changing treatment,intensive care requirement, hospitalization period and death rate
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

Risk factors for early onset severe community-acquired pneumonia complications
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018




The incidence and risk factors of ventilator associated pneumonia on the mortality in patients with traumatic brain injury
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012


Incidence, risk factors and outcomes of nonresolving pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010

Role of biomarkers of systemic inflammation in the prediction of mortality and/or severe complications in community adquired pneumonia
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019


Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Prediction of complications development and lethal outcome in patients with community-acquired pneumonia
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011


Interleukin-6 levels as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

Risk factors of treatment failure of community acquired pneumonia in patients with COPD
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008